Glutamine suppresses PGE2 synthesis and breast cancer growth

Vicki Klimberg, Jacki Kornbluth, Yihong Cao, A. Dang, Sarah Blossom, Robert F. Schaeffer

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Reduced natural killer (NK) activity found in tumor-bearing hosts has been associated with high levels of prostaglandin E2 (PGE2) produced by monocytes in vitro. We have previously demonstrated a dependence of NK cell activity on glutamine (GLN) levels in vitro and in vivo. Further, glutathione (GSH) is antagonistic to PGE2 synthesis. We hypothesized that GLN, through increased GSH production, leads to decreased PGE2 synthesis and upregulation of NK cytotoxic activity. To test this, we examined the effects of oral GLN on GSH and PGE2 concentrations, NK activity and tumor growth in a rat breast cancer model. Starting on the day of MTF-7 tumor implantation 18 Fisher 344 rats were pair-fed chow and gavaged with 1 g/kg/day GLN (n = 9) or an isonitrogenous amount of Freamine (FA) (n = 9). Seven weeks after tumor implantation rats were sacrificed. Tumors were measured, weighed, and processed for tumor morphometrics. Spleens were removed, lymphocytes isolated and assayed for NK activity. Blood GLN, GSH, and PGE2 concentrations were measured. Over the 7-week study period tumor growth was decreased by approximately 40% in the GLN-supplemented group. This decrease in growth was associated with a 2.5 fold greater NK activity in the GLN-fed rats vs FA-fed rats. This correlated with a 25% rise in GSH concentration and a proportional decrease in PGE2 synthesis. Decreased tumor volume in rats fed GLN was not associated with changes in morphometrics. Oral GLN supplementation enhances INK activity resulting in decreased tumor growth. The enhanced NK activity seen with oral GLN supplementation in the tumor-bearing host is associated with GSH mediated suppression of PGE2 synthesis.

Original languageEnglish (US)
Pages (from-to)293-297
Number of pages5
JournalJournal of Surgical Research
Volume63
Issue number1
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Glutamine
Dinoprostone
Breast Neoplasms
Growth
Neoplasms
Tumor Burden
Natural Killer Cells
Glutathione
Monocytes
Up-Regulation
Spleen
Lymphocytes

ASJC Scopus subject areas

  • Surgery

Cite this

Klimberg, V., Kornbluth, J., Cao, Y., Dang, A., Blossom, S., & Schaeffer, R. F. (1996). Glutamine suppresses PGE2 synthesis and breast cancer growth. Journal of Surgical Research, 63(1), 293-297. https://doi.org/10.1006/jsre.1996.0263

Glutamine suppresses PGE2 synthesis and breast cancer growth. / Klimberg, Vicki; Kornbluth, Jacki; Cao, Yihong; Dang, A.; Blossom, Sarah; Schaeffer, Robert F.

In: Journal of Surgical Research, Vol. 63, No. 1, 1996, p. 293-297.

Research output: Contribution to journalArticle

Klimberg, V, Kornbluth, J, Cao, Y, Dang, A, Blossom, S & Schaeffer, RF 1996, 'Glutamine suppresses PGE2 synthesis and breast cancer growth', Journal of Surgical Research, vol. 63, no. 1, pp. 293-297. https://doi.org/10.1006/jsre.1996.0263
Klimberg, Vicki ; Kornbluth, Jacki ; Cao, Yihong ; Dang, A. ; Blossom, Sarah ; Schaeffer, Robert F. / Glutamine suppresses PGE2 synthesis and breast cancer growth. In: Journal of Surgical Research. 1996 ; Vol. 63, No. 1. pp. 293-297.
@article{7704cb828737476f96628cd109ae923a,
title = "Glutamine suppresses PGE2 synthesis and breast cancer growth",
abstract = "Reduced natural killer (NK) activity found in tumor-bearing hosts has been associated with high levels of prostaglandin E2 (PGE2) produced by monocytes in vitro. We have previously demonstrated a dependence of NK cell activity on glutamine (GLN) levels in vitro and in vivo. Further, glutathione (GSH) is antagonistic to PGE2 synthesis. We hypothesized that GLN, through increased GSH production, leads to decreased PGE2 synthesis and upregulation of NK cytotoxic activity. To test this, we examined the effects of oral GLN on GSH and PGE2 concentrations, NK activity and tumor growth in a rat breast cancer model. Starting on the day of MTF-7 tumor implantation 18 Fisher 344 rats were pair-fed chow and gavaged with 1 g/kg/day GLN (n = 9) or an isonitrogenous amount of Freamine (FA) (n = 9). Seven weeks after tumor implantation rats were sacrificed. Tumors were measured, weighed, and processed for tumor morphometrics. Spleens were removed, lymphocytes isolated and assayed for NK activity. Blood GLN, GSH, and PGE2 concentrations were measured. Over the 7-week study period tumor growth was decreased by approximately 40{\%} in the GLN-supplemented group. This decrease in growth was associated with a 2.5 fold greater NK activity in the GLN-fed rats vs FA-fed rats. This correlated with a 25{\%} rise in GSH concentration and a proportional decrease in PGE2 synthesis. Decreased tumor volume in rats fed GLN was not associated with changes in morphometrics. Oral GLN supplementation enhances INK activity resulting in decreased tumor growth. The enhanced NK activity seen with oral GLN supplementation in the tumor-bearing host is associated with GSH mediated suppression of PGE2 synthesis.",
author = "Vicki Klimberg and Jacki Kornbluth and Yihong Cao and A. Dang and Sarah Blossom and Schaeffer, {Robert F.}",
year = "1996",
doi = "10.1006/jsre.1996.0263",
language = "English (US)",
volume = "63",
pages = "293--297",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Glutamine suppresses PGE2 synthesis and breast cancer growth

AU - Klimberg, Vicki

AU - Kornbluth, Jacki

AU - Cao, Yihong

AU - Dang, A.

AU - Blossom, Sarah

AU - Schaeffer, Robert F.

PY - 1996

Y1 - 1996

N2 - Reduced natural killer (NK) activity found in tumor-bearing hosts has been associated with high levels of prostaglandin E2 (PGE2) produced by monocytes in vitro. We have previously demonstrated a dependence of NK cell activity on glutamine (GLN) levels in vitro and in vivo. Further, glutathione (GSH) is antagonistic to PGE2 synthesis. We hypothesized that GLN, through increased GSH production, leads to decreased PGE2 synthesis and upregulation of NK cytotoxic activity. To test this, we examined the effects of oral GLN on GSH and PGE2 concentrations, NK activity and tumor growth in a rat breast cancer model. Starting on the day of MTF-7 tumor implantation 18 Fisher 344 rats were pair-fed chow and gavaged with 1 g/kg/day GLN (n = 9) or an isonitrogenous amount of Freamine (FA) (n = 9). Seven weeks after tumor implantation rats were sacrificed. Tumors were measured, weighed, and processed for tumor morphometrics. Spleens were removed, lymphocytes isolated and assayed for NK activity. Blood GLN, GSH, and PGE2 concentrations were measured. Over the 7-week study period tumor growth was decreased by approximately 40% in the GLN-supplemented group. This decrease in growth was associated with a 2.5 fold greater NK activity in the GLN-fed rats vs FA-fed rats. This correlated with a 25% rise in GSH concentration and a proportional decrease in PGE2 synthesis. Decreased tumor volume in rats fed GLN was not associated with changes in morphometrics. Oral GLN supplementation enhances INK activity resulting in decreased tumor growth. The enhanced NK activity seen with oral GLN supplementation in the tumor-bearing host is associated with GSH mediated suppression of PGE2 synthesis.

AB - Reduced natural killer (NK) activity found in tumor-bearing hosts has been associated with high levels of prostaglandin E2 (PGE2) produced by monocytes in vitro. We have previously demonstrated a dependence of NK cell activity on glutamine (GLN) levels in vitro and in vivo. Further, glutathione (GSH) is antagonistic to PGE2 synthesis. We hypothesized that GLN, through increased GSH production, leads to decreased PGE2 synthesis and upregulation of NK cytotoxic activity. To test this, we examined the effects of oral GLN on GSH and PGE2 concentrations, NK activity and tumor growth in a rat breast cancer model. Starting on the day of MTF-7 tumor implantation 18 Fisher 344 rats were pair-fed chow and gavaged with 1 g/kg/day GLN (n = 9) or an isonitrogenous amount of Freamine (FA) (n = 9). Seven weeks after tumor implantation rats were sacrificed. Tumors were measured, weighed, and processed for tumor morphometrics. Spleens were removed, lymphocytes isolated and assayed for NK activity. Blood GLN, GSH, and PGE2 concentrations were measured. Over the 7-week study period tumor growth was decreased by approximately 40% in the GLN-supplemented group. This decrease in growth was associated with a 2.5 fold greater NK activity in the GLN-fed rats vs FA-fed rats. This correlated with a 25% rise in GSH concentration and a proportional decrease in PGE2 synthesis. Decreased tumor volume in rats fed GLN was not associated with changes in morphometrics. Oral GLN supplementation enhances INK activity resulting in decreased tumor growth. The enhanced NK activity seen with oral GLN supplementation in the tumor-bearing host is associated with GSH mediated suppression of PGE2 synthesis.

UR - http://www.scopus.com/inward/record.url?scp=0029887479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029887479&partnerID=8YFLogxK

U2 - 10.1006/jsre.1996.0263

DO - 10.1006/jsre.1996.0263

M3 - Article

VL - 63

SP - 293

EP - 297

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -